Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Steven M. Paul currently holds 41,666 shares of Karuna Therapeutics, Inc. (KRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steven M. Paul has been a net seller of KRTX stock. They have purchased $1.9M and sold $81.6M worth of shares.
Steven M. Paul's most recent insider trade was on Sep 12, 2025, when they purchased 13,382 shares at $24.97 per share.
Steven M. Paul serves as Executive at Karuna Therapeutics, Inc. (KRTX). They have executed 201 insider transactions totaling $83.6M over their tenure at the company.
Steven M. Paul holds the position of Executive at Karuna Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Steven M. Paul has shown a selling trading pattern, with $1.9M in total purchases and $81.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Steven M. Paul was on Mar 18, 2024, when they sold $244.3M worth of KRTX shares. This transaction involved 757,045 shares at $322.73 per share.
Steven M. Paul currently owns 41,666 shares of Karuna Therapeutics, Inc. (KRTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Steven M. Paul's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Steven M. Paul has 201 Form 4 filings on record as an insider at Karuna Therapeutics, Inc..
Set alerts for Steven M. Paul and 40,000+ other insiders.